Search / 98 results found Showing: 1-10 of 98
FRIDAY, Jan. 28, 2022 (HealthDay News) -- For patients with rheumatoid arthritis aged 50 years or older with one or more additional cardiovascular risk factors, increased risks for major adverse cardiovascular events (MACE) and cancer are seen with tofacitinib compared with a tumor necrosis factor (TNF) inhibitor, according to a study published in the Jan. 27 issue of the New England Journal of Medicine.
FRIDAY, Jan. 28, 2022 (HealthDay News) -- When delivering a liver cancer diagnosis, Dr. Thomas Marron pulls no punches: "Liver cancer is one of the deadliest cancers," he tells patients.
THURSDAY, Jan. 27, 2022 (HealthDay News) -- The youngest adults have the greatest burden of distant-stage early-onset colorectal adenocarcinoma, according to a study published online Jan. 26 in Cancer Epidemiology, Biomarkers & Prevention.
WEDNESDAY, Jan. 26, 2022 (HealthDay News) -- Low-dose computed tomography (LDCT) screening of mostly nonsmoking Asian women is associated with considerable early-stage lung cancer overdiagnosis, according to a study published online Jan. 18 in JAMA Internal Medicine.
THURSDAY, Jan. 27, 2022 (HealthDay News) -- Finding the right medication for rheumatoid arthritis isn't easy, and a newer pill against the disease carries higher risks of heart attack, stroke and cancer than older RA drugs, a new clinical trial confirms.
THURSDAY, Jan. 27, 2022 (HealthDay News) -- Taking vitamin D supplements may help stave off psoriasis, rheumatoid arthritis, lupus and other autoimmune diseases, a new study suggests.
TUESDAY, Jan. 25, 2022 (HealthDay News) -- A four-marker protein panel (4MP), including the precursor form of surfactant protein B, cancer antigen 125, carcinoembryonic antigen, and cytokeratin-19 fragment, combined with the prostate lung colorectal ovarian cancer risk prediction model (PLCOm2012) may improve risk assessment and help identify candidates for lung cancer screening, according to a study published online Jan. 7 in the Journal of Clinical Oncology.
MONDAY, Jan. 24, 2022 (HealthDay News) -- Night shift work may increase the risk for chronic lymphocytic leukemia (CLL), according to a study published online Jan. 13 in Occupational & Environmental Medicine.